Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis
Pilar Navarro(Electric Vehicle Challenge), Alfredo J. Lucendo(Hospital General de Tomelloso), Danila Guagnozzi(Hebron University), Antonia Perelló, Sergio Casabona, Carmen Alcolea-Valero(Hospital General de Tomelloso), Pedro Majano(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Natalia Serrano-Moya(Hospital General de Tomelloso), S. Riva, Matteo Ghisa(University of Padua), José María Olalla(Servicio de Salud de Castilla La Mancha), Edoardo Savarino(University of Padua), Ángel Arias(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Emilio J. Laserna‐Mendieta(Hospital General de Tomelloso), Guillermo Ortega-Rabbione(Hospital Universitario de La Princesa), Cecílio Santander
Cited by 62
Related Papers
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
Eosinophilic Esophagitis in Adults Is Associated With IgG4 and Not Mediated by IgE
|Gastroenterology|2014|487
Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis
|New England Journal of Medicine|2022|452
Systematic review with meta‐analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population‐based studies
|Alimentary Pharmacology & Therapeutics|2019|309
Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease
|Nature Communications|2020|283